在隔膜肌切除手术后,突然死亡的预测因素是如何改变的?
Juan Pablo Costabel1, Ivana Seia1, Diego Conde1
1Cardiology Department, Instituto Cardiovascular de Buenos Aires, Blanco Encalada 1543, 1428 CABA, Argentina.
Current problems in cardiology
|March 30, 2024
概括
扩展性隔膜肌切除手术显著降低了缩性心肌病患者突然死亡预测因素. 这种程序可能会降低受影响个体突然心脏死亡的风险.
科学领域:
- 心脏病学 心脏病学
- 心脏外科手术 心脏外科手术
- 临床医学 临床医学
背景情况:
- 过度缩性心肌病 (HCM) 呈现出突然死亡的高风险.
- 扩展性隔膜切除术是一种建议用于减轻HCM突发死亡事件的手术干预.
- 这项研究旨在评估扩展性隔膜肌切除术对突然死亡预测因素的影响.
研究的目的:
- 评估延长隔膜肌切除术后突然死亡预测因子患病率的变化.
- 确定扩展隔膜肌切除术在降低HCM患者突然心脏死亡风险因素方面的疗效.
主要方法:
- 94名患有症状的HCM患者接受了扩展性隔膜肌切除术.
- 在手术前和手术后三个月评估了突然死亡风险因素.
- 评估的参数包括隔膜厚度,左心脏直径,心室内梯度,心律失常和风险评分.
主要成果:
- 观察到最大隔膜厚度 (21.3至14毫米) 和左心脏直径 (51至47毫米) 的显著减少.
- 静止和瓦萨尔瓦诱导的心室内梯度明显减少 (分别为49.2至6.4毫米度和93.9至8.7毫米度).
- 减少非持续性心室动脉冲动的患病率 (6%至2%),心房 (30%至15%),改善了运动压力回声结果;欧洲心脏病学会突然死亡风险得分从3.32降至1.44.
结论:
- 扩展性隔膜肌切除术有效地减少了HCM患者突然死亡的多种预测因素.
- 观察到的风险因素的减少支持了这种手术后死亡率降低的可能性.
- 截面肌切除术是管理HCM及其相关风险的有价值的治疗选择.
相关概念视频
01:27Mitral Stenosis IV: Nursing Management
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...